MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Orthostatic hypotension exacerbates gray matter atrophy related to REM sleep behavior disorder in de novo Parkinson’s disease

    T. Shiraishi, T. Umehara, Y. Iguchi (Tokyo, Japan)

    Objective: As the previous studies indicated that other factors including REM sleep behavior disorder (RBD) and olfactory dysfunction were also associated with cognitive decline and…
  • 2023 International Congress

    Clinical and genetic characteristics of a cohort of 20 patients with confirmed biallelic pathogenic SPG7 mutations from the North West of England

    R. Heartshorne, J. Proudfoot-Jones, A. Barakat, M. Bonello (Liverpool, United Kingdom)

    Objective: To identify the prevalence and phenotype of patients with biallelic pathogenic SPG7 mutations Background: Spastic Paraplegia Type 7 (SPG7) is an autosomal recessive disorder…
  • 2023 International Congress

    Specific ethnicity could have different risk factors for Parkinson’s disease: a descriptive study

    S. Marisdina, S. Handayani, Y. Diansari, M. Odiesta (Palembang, Indonesia)

    Objective: The objective of this study was to determine if there were different risk and protective factors for Parkinson’s disease (PD) based on subethnicity in…
  • 2023 International Congress

    In vitro α–synuclein aggregation and propagation model

    F. Kapucu, I. Tujula, O. Kulta, L. Sukki, V. Vuolanto, A. Vinogradov, P. Kallio, S. Narkilahti (Tampere, Finland)

    Objective: Developing an in vitro α–synuclein (α-s) aggregation and propagation model of human cortical networks for functionality studies. Background: Studying α–s pathology and its effects…
  • 2023 International Congress

    Plasma biomarkers in iRBD patients serve as potential markers of early PD and motor severity

    B. Huxford, C. Simonet-Hernandez, L. Pérez-Carbonell, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: We aimed  to investigate biomarkers of inflammation and neuroaxonal damage in people with isolated REM sleep behaviour disorder (iRBD) compared to controls, and understand…
  • 2023 International Congress

    Levodopa-induced orthostatic hypotension in a large cohort of patients with Parkinson’s disease undergoing an acute levodopa challenge test

    X. Wang, S. Mei, C. Han, P. Chan (Beijing, China)

    Objective: We aimed to investigate the frequency and associated risk factors for Levodopa-induced orthostatic hypotension (OH) in a large cohort of PD patients underwent acute…
  • 2023 International Congress

    Novel application of the Timed Up and Go Scale as a reliable tool to measure functional improvement and fall prevention after inpatient Parkinson’s Disease specific rehabilitation for advanced stages of PD

    M. Mccrossin, L. Rubin, C. Claro, A. Persaud, E. Finlay, A. Sturman, D. Barreto, A. John, M. Tursi, A. Di Rocco (Glen Cove, USA)

    Objective: To determine whether the “Timed Up and Go” (TUG) scale can be effectively utilized in patients with advanced Parkinson’s disease (PD) as an outcome…
  • 2023 International Congress

    Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson’s disease: A Systematic Review and Network Meta-Analysis

    SM. Li, YC. Zheng, C. Yang, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)

    Objective: We performed meta-analysis to determine the diagnostic and differential diagnostic value of α-syn SAAs for PD, and to investigate the optimal specimens. Background: Alpha-synuclein…
  • 2023 International Congress

    Fluorescence-lifetime ophthalmoscopy findings in Parkinson’s disease patients with visual disturbances

    K. Shivok, E. Affel, M. Alizadeh, T-W. Liang, D. Kremens, R. Sergott (Philadelphia, USA)

    Objective: We identified fluorescence-lifetime ophthalmoscopy changes in Parkinson’s disease (PD) patients experiencing visual disturbances. Background: Fluorescence-lifetime ophthalmoscopy (FLIO), a novel in vivo imaging method generating…
  • 2023 International Congress

    Brain functional state mapping in resting state and network alteration in Spinocerebellar Ataxia Type 2 in comparison with healthy controls

    P. Pankaj, S. Kumaran, A. Srivastava, A. Garg, R. Agarwal, A. Nehra (New Delhi, India)

    Objective: The aim of this study is to map the brain functional network alterations by estimating functional connectivity of brain structures in spinocerebellar ataxia type 2.…
  • « Previous Page
  • 1
  • …
  • 286
  • 287
  • 288
  • 289
  • 290
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley